IPONOVA — India's IPO Intelligence Platform

Molbio Diagnostics Ltd IPO

Listed · Mainboard · BSE, NSE

Last updated:  ·  Compiled by IPONOVA Editorial Desk  ·  How we source data

IPO Details

Price Band₹768.00–₹807.00
Lot Size18 shares
Issue Size₹940 Cr
Open Date10 Aug 26
Close Date12 Aug 26
Listing Date17 Aug 26
ExchangeBSE, NSE
Subscription70.27x

About Molbio Diagnostics Ltd

Molbio Diagnostics Limited is a global point-of-care (POC) molecular diagnostics company engaged in the research, development, manufacturing, and commercialization of rapid diagnostic solutions for infectious and non-communicable diseases.

Anchor Investor Allotment

Total Investors33
Total Shares3,487,717
Total Allocation100.02%
Total Investment₹281.46 Cr
Allotment Date13 Aug 2026
30-Day Lock-in Ends25 Sep 2026
90-Day Lock-in Ends23 Dec 2026
Anchor Investor Name Eq. Shares Allocation % Bid Price Investment Amount 30-Day Lock-in 90-Day Lock-in
GOLDMAN SACHS FUNDS - GOLDMAN SACHS INDIA EQUITY PORTFOLIO 309,780 8.88% ₹807.00 ₹25.00 Cr 25 Sep 2026 23 Dec 2026
NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA PHARMA FUND RCT-RPF 247,842 7.11% ₹807.00 ₹20.00 Cr 25 Sep 2026 23 Dec 2026
INTERNATIONAL FINANCE CORPORATION* 247,842 7.11% ₹807.00 ₹20.00 Cr 25 Sep 2026 23 Dec 2026
BLACKROCK GLOBAL FUNDS - INDIA FUND 247,842 7.11% ₹807.00 ₹20.00 Cr 25 Sep 2026 23 Dec 2026
MIRAE ASSET HEALTHCARE FUND MIRAHCFD 247,842 7.11% ₹807.00 ₹20.00 Cr 25 Sep 2026 23 Dec 2026
ICICI PRUDENTIAL QUALITY FUND 185,886 5.33% ₹807.00 ₹15.00 Cr 25 Sep 2026 23 Dec 2026
ICICI PRUDENTIAL EXPORTS AND SERVICES FUND 148,698 4.26% ₹807.00 ₹12.00 Cr 25 Sep 2026 23 Dec 2026
KOTAK CONTRA FUND 144,576 4.15% ₹807.00 ₹11.67 Cr 25 Sep 2026 23 Dec 2026
KOTAK MAHINDRA TRUSTEE CO LTD A/C KOTAK HEALTHCARE FUND 144,576 4.15% ₹807.00 ₹11.67 Cr 25 Sep 2026 23 Dec 2026
KOTAK MAHINDRA TRUSTEE CO LTD A/C KOTAK CONSUMPTION FUND 144,558 4.14% ₹807.00 ₹11.67 Cr 25 Sep 2026 23 Dec 2026
HDFC MUTUAL FUND - HDFC PHARMA AND HEALTHCARE FUND 138,006 3.96% ₹807.00 ₹11.14 Cr 25 Sep 2026 23 Dec 2026
MOTILAL OSWAL LARGE CAP FUND 123,930 3.55% ₹807.00 ₹10.00 Cr 25 Sep 2026 23 Dec 2026
TATA INDIA PHARMA & HEALTHCARE FUND 123,930 3.55% ₹807.00 ₹10.00 Cr 25 Sep 2026 23 Dec 2026
NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA INNOVATION FUND 123,912 3.55% ₹807.00 ₹10.00 Cr 25 Sep 2026 23 Dec 2026
HDFC VALUE FUND 108,432 3.11% ₹807.00 ₹8.75 Cr 25 Sep 2026 23 Dec 2026
HDFC MUTUAL FUND - HDFC INNOVATION FUND 108,414 3.11% ₹807.00 ₹8.75 Cr 25 Sep 2026 23 Dec 2026
EDELWEISS TRUSTEESHIP CO LTD AC - EDELWEISS MF AC - EDELWEISS EQUITY SAVINGS FUND 92,934 2.66% ₹807.00 ₹7.50 Cr 25 Sep 2026 23 Dec 2026
HDFC LIFE INSURANCE COMPANY LIMITED 88,597 2.54% ₹807.00 ₹7.15 Cr 25 Sep 2026 23 Dec 2026
BAJAJ LIFE INSURANCE LIMITED 88,596 2.54% ₹807.00 ₹7.15 Cr 25 Sep 2026 23 Dec 2026
WHITEOAK CAPITAL PHARMA AND HEALTHCARE FUND 80,568 2.31% ₹807.00 ₹6.50 Cr 25 Sep 2026 23 Dec 2026
HDFC MUTUAL FUND - HDFC MNC FUND 78,858 2.26% ₹807.00 ₹6.36 Cr 25 Sep 2026 23 Dec 2026
GOLDMAN SACHS ETF TRUST - GOLDMAN SACHS INDIA EQUITY ETF 61,974 1.78% ₹807.00 ₹5.00 Cr 25 Sep 2026 23 Dec 2026
WHITEOAK CAPITAL AGGRESSIVE HYBRID FUND 43,362 1.24% ₹807.00 ₹3.50 Cr 25 Sep 2026 23 Dec 2026
ISIF EQUITY LONG-SHORT FUND 37,170 1.07% ₹807.00 ₹3.00 Cr 25 Sep 2026 23 Dec 2026
AXIS MAX LIFE INSURANCE LIMITED A/C SUSTAINABLE EQUITY FUND - ULIF02505/10/21SUSTAINEQU104 35,104 1.01% ₹807.00 ₹2.83 Cr 25 Sep 2026 23 Dec 2026
AXIS MAX LIFE INSURANCE LIMITED A/C - ULIF00225/06/04LIFEBALANC104 - BALANCED FUND 33,367 0.96% ₹807.00 ₹2.69 Cr 25 Sep 2026 23 Dec 2026
EDELWEISS TRUSTEESHIP CO LTD AC - EDELWEISS MF AC- EDELWEISS RECENTLY LISTED IPO FUND 30,996 0.89% ₹807.00 ₹2.50 Cr 25 Sep 2026 23 Dec 2026
AXIS MAX LIFE INSURANCE LIMITED PENSION MAXIMISER FUND (ULIF01715/02/13PENSMAXIMI104) 11,401 0.33% ₹807.00 ₹9,200,607 25 Sep 2026 23 Dec 2026
AXIS MAX LIFE INSURANCE LIMITED A/C UHG2S - INDIA CONSUMPTION OPPORTUNITIES FUND 2,625 0.08% ₹807.00 ₹2,118,375 25 Sep 2026 23 Dec 2026
AXIS MAX LIFE INSURANCE LIMITED A/C UMFPH - HIGH GROWTH PENSION FUND 2,625 0.08% ₹807.00 ₹2,118,375 25 Sep 2026 23 Dec 2026
AXIS MAX LIFE INSURANCE LIMITED A/C - ULGF00217/04/06GRATBALANC104 - GROUP GRATUITY BALANCED FUND 1,750 0.05% ₹807.00 ₹1,412,250 25 Sep 2026 23 Dec 2026
AXIS MAX LIFE INSURANCE LIMITED PENSION PRESERVER FUND(ULIF01815/02/13PENSPRESER104) 862 0.02% ₹807.00 ₹695,634 25 Sep 2026 23 Dec 2026
AXIS MAX LIFE INSURANCE LIMITED A/C - ULIF00625/11/05PENSBALANC104 - PENSION BALANCED FUND 862 0.02% ₹807.00 ₹695,634 25 Sep 2026 23 Dec 2026
TOTAL (33 investors) 3,487,717 100.02% ₹281.46 Cr

Lock-in dates calculated from allotment date (30 & 90 calendar days, adjusted to next NSE trading day as per exchange holiday calendar).

Frequently Asked Questions

When does the Molbio Diagnostics Ltd IPO open and close?
The Molbio Diagnostics Ltd IPO opens for subscription on 10 Aug 26. It closes on 12 Aug 26.
What is the price band of Molbio Diagnostics Ltd IPO?
The price band of Molbio Diagnostics Ltd IPO is ₹768.00 to ₹807.00 per share.
What is the minimum lot size for Molbio Diagnostics Ltd IPO?
The minimum lot size for Molbio Diagnostics Ltd IPO is 18 shares, requiring a minimum investment of ₹14,526.
When will Molbio Diagnostics Ltd list on stock exchanges?
Molbio Diagnostics Ltd is expected to list on BSE, NSE on 17 Aug 26.
How can I check Molbio Diagnostics Ltd IPO allotment status?
You can check Molbio Diagnostics Ltd IPO allotment status on IPONOVA after the basis of allotment is finalized, or via the registrar's website using your PAN number, application number, or DP/Client ID.
How to apply for Molbio Diagnostics Ltd IPO?
You can apply for Molbio Diagnostics Ltd IPO through your broker's app (Zerodha, Groww, Upstox, etc.) or via UPI-enabled net banking using ASBA. Submit the application during the IPO subscription window with the price within the band ₹768.00 to ₹807.00 per share.

Data Sources & Verification

This page aggregates publicly available data for the Molbio Diagnostics Ltd IPO from the following authoritative sources:

Subscription, allotment and listing data is refreshed throughout each IPO's issue window directly from the exchanges and registrars listed above. Always read the official offer document (RHP) before applying. For corrections, contact IPONOVA Editorial Desk.

Read our full editorial methodology & sourcing standards →

Disclaimer: IPONOVA is an information platform only. We are not SEBI-registered investment advisors. All data is presented for educational and informational purposes and is sourced from publicly available filings on BSE, NSE and SEBI. Investment in securities market is subject to market risks. Read all related documents carefully before investing. Past performance is not indicative of future returns. Please consult a SEBI-registered investment advisor before making any investment decisions.